Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy [NA]
A not-yet-recruiting clinical trial, sponsored by Shanghai University of Traditional Chinese Medicine, is evaluating electroacupuncture to i…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients [NA]
This ClinicalTrials.gov record notes a recruiting study evaluating a physical activity program with peer-motivational support for men with p…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: 68Ga-XACP3 PET/CT in Prostate Cancer [NA]
Clinical trial investigating the PET/CT imaging agent 68Ga-XACP3 for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life [Phase 2]
Phase 2 clinical trial evaluating the effects of eicosapentaenoic acid (EPA) on prostate cancer cell proliferation and patient quality of li…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Prospective Evaluation of Early Acupuncture for Immediate Continence Enhancement After Prostatectomy [NA]
A prospective clinical trial evaluating early acupuncture to improve immediate urinary continence after prostatectomy; the study is currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
A clinical trial update describes evaluating a quantum-detection AI method to characterize single-molecule cfDNA for early detection of pros…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Memantine Hydrochloride in Prostate Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating memantine hydrochloride in metastatic castration-resistant prostate cancer and other prostate cancers, c…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome [NA]
A clinical trial update describing a study that evaluates prostate cancer burden and heterogeneity and explores correlations with liquid bio…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study [Phase 2]
Phase 2 single-arm trial evaluating the combination of homoharringtonine with androgen deprivation therapy as neoadjuvant treatment for pros…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting
A study evaluating prognostic factors in prostate cancer for patients managed with watchful waiting. The trial is currently active but not r…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer
This ClinicalTrials.gov update describes a study evaluating sleep quality in prostate cancer patients receiving hormonal therapy and in pati…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Lifestyle Intervention in Patients With Metastatic Prostate Cancer [NA]
A clinical trial is investigating a lifestyle intervention for metastatic prostate cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating Fasudil hydrochloride plus a PD-1 inhibitor in combination with androgen deprivation as neoadjuvant th…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients
A clinical trial is investigating blood-based biomarkers to predict the response to therapy in prostate cancer patients and is currently rec…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
An ongoing clinical study at University of Erlangen-Nürnberg Medical School is examining immune biomarkers in prostate cancer patients treat…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: The Influence of Music on perceiVed paIn and leVels of Anxiety whiLe unDergoing transperIneal Prostate Biopsy: the VIVALDI Trial [NA]
The VIVALDI Trial investigates whether music therapy reduces perceived pain and anxiety during transperineal prostate biopsy in men with sus…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
This AdventHealth-sponsored study is an ongoing trial evaluating strategies for preventive breast, lung, and prostate cancer screenings in c…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.
This ClinicalTrials.gov study aims to evaluate the safety of TALZENNA (talazoparib) in people with prostate cancer and is currently active b…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. [NA]
This clinical trial investigates the clinical, genetic, and environmental determinants of progression in prostate cancer.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer [NA]
This Clinical Trial Update notes an active but not recruiting study comparing stereotactic body radiotherapy to intensity-modulated radiothe…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET [Phase 4]
A Phase 4 clinical trial is evaluating fluciclovine PET imaging to detect biochemical recurrence of prostate cancer in patients who have a n…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating an evidence-based focal cryotherapy protocol for focal ablation in intermediate-risk prostate cancer is …
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer [Phase 2]
This report describes an ongoing Phase 2 clinical trial evaluating risk-stratified de-escalated hormone therapy in combination with radiatio…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Stereotactic Magnetic Resonance Guided Radiation Therapy [NA]
Clinical trial update on stereotactic MR-guided radiation therapy for multiple cancer types; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
This clinical trial update notes that a study evaluating Flotufolastat F-18 PET imaging for men with very low PSA recurrence of prostate can…